FY2026 · ended Mar 31, 2026 · Revenue $179.02M, -21.1% YoY · Filed Jun 2, 2026
PetMed Express, Inc. (PETS) files with the SEC under industry code 5912, Retail-Drug Stores and Proprietary Stores. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $179.0 million and a net loss of $57.3 million. Free cash flow was -$33.0 million. As of Jun 30, 2026 it held $13.1 million in cash and investments and $414,000 in total debt.
Revenue (TTM)
$168.86M
-20.3% vs year-ago TTM
Net income (TTM)
$-29.28M
+33.7% vs year-ago TTM
Operating cash flow (TTM)
$-23.81M
-2569.9% vs year-ago TTM
Free cash flow (TTM)
$-27.77M
-483.7% vs year-ago TTM
EPS (TTM)
$-1.38
+35.6% vs year-ago TTM
Dividend per share
$0.00
Shares outstanding
21.37M
+1.7% vs prior year
Net cash
$12.66M
as of Jun 30, 2026
Operating margin
-18.2%
FY 2027
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- PETS (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- FL
- Headquarters
- Delray Beach, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1040130
Other Retail-Drug Stores and Proprietary Stores companies
- CVS HEALTH Corp CVS
- Guardian Pharmacy Services, Inc. GRDN
- 111, Inc. YI
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Mar 31, 2026 |
FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2023 Mar 31, 2023 |
FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $179.0M | $227.0M | $281.1M | $256.6M | $272.3M |
| Operating income | -$58.7M | -$1.5M | -$8.2M | $6.1M | $24.3M |
| Net income | -$57.3M | -$6.3M | -$7.5M | $5.1M | $18.7M |
| Diluted EPS | -$2.74 | -$0.30 | -$0.37 | $0.25 | $0.92 |
| Operating cash flow | -$28.4M | $4.7M | $4.3M | $27.8M | $18.5M |
| Free cash flow | -$33.0M | -$395,000 | -$194,000 | $22.5M | $16.7M |
| Total assets | $81.2M | $148.7M | $169.9M | $167.5M | $179.7M |
| Total liabilities | $52.3M | $63.6M | $73.2M | $57.5M | $56.2M |
| Stockholders' equity | $28.9M | $85.1M | $96.7M | $110.0M | $123.5M |
| Cash and investments | $21.4M | $54.7M | $55.3M | $104.1M | $111.1M |
| Total debt | $534,000 | $996,000 | $1.5M | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 28, 2026 | Sep 27, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 21, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 17, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 12, 2026 | Aug 11, 2026 |
All 1001 PetMed Express, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.